TGFB1 and glioblastoma: Only Hou et al. demonstrated the ability of DMAMCL to inhibit TGF-β-induced proliferation and spheroid growth of patient-derived glioblastoma stem cells [24], and enhydrin was found to decrease TGF-β expression during PMT blockade in U87 and LN229 cells [86].